Analyst Ratings for Haemonetics Corp. (HAE)Updated: 2017-07-27
An average rating of Hold has been given to Haemonetics Corp. (NYSE:HAE) by analysts covering the stock. About 30 days ago, HAE was issued an average rating of Hold.
9 analysts issued ratings on the stock, where 2 gave HAE a buy rating, 0 issued an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
Investment analysts gave a few price targets for HAE. The most optimistic price target was 50, implying potential capital gains of 26.52 percent. The minimum price target given was 38, which equates to a potential downside of -3.85 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -1.56 percent. That number becomes 0 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0.32 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.88 percent.
People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts revised their estimates downwards. Also over the last month, 2 analysts increased their estimates for the FY earnings, compared to 1 analysts that revised their FY estimates downwards.
HAE has a 52-week high of 43.62 and a 52-week low of 29.75. The current market price is above the trailing year's low by 32.84 percent, and below the high by 9.4 percent. HAE has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HAE value stock report compares HAE to some of its peers using value stock charts. The market cap of HAE is $2.08 billion. HAE is estimated to release their earnings results for the quarter on 0000-00-00, days from today.